Expertise Gaps at Critical Moments
Small-to-mid-size biopharma companies face a persistent dilemma:
- ►You need C-level expertise to de-risk pivotal trials and regulatory submissions
- ►You can't afford full-time executives with the right credentials and track record
- ►Generic consultants lack the hands-on experience with your specific therapeutic area and technology needs
- ►Time is critical—waiting months for the right guidance can derail funding timelines
The consequence? Protocol design flaws that lead to slow enrollment, costly amendments, or clinical holds. According to Tufts CSDD, 57% of protocols require substantial amendments, adding $500K–$2M in costs and 4–6 months in delays.
The Program Readiness Board Model
Instead of hiring a large consulting firm where you get their B-team, or struggling to find the right expert through traditional networks, AyurDatta provides:
The Program Readiness Board — for your program, not a patient. Unlike a traditional patient-level tumor board, our PRB evaluates the program — integrating clinical, regulatory, safety, data, and technology readiness into one board-level view. A named physician chairs each session and signs every recommendation.
Precision-Matched Expertise
We assemble a custom Program Readiness Board (PRB) from our vetted network of KOLs with direct experience in your therapeutic area, technology stack, and regulatory pathway.
Rapid Deployment
- ►72-hour initial assessment of your protocol and risk landscape
- ►7-day expert team assembly with the right clinical, regulatory, and technology specialists
- ►2–6 week engagements with clear deliverables and guaranteed founder involvement
Confidential & Strategic
All engagements operate under NDA, positioning our experts as your strategic advisors—not vendor representatives with conflicts of interest.
Powered by the IHASG framework. The PRB is the expert layer within AyurDatta's Integrated Holistic AI Safety Governance (IHASG) standard — the named physicians and specialists who review what AI flags, adjudicate benefit-risk, and sign the documented decision trail.
Learn about IHASG →Credentials That Matter
Clinical & Regulatory Expertise
Our clinical KOLs bring proven track records, not just credentials:
- ►Experience filing 100+ INDs and 30+ NDAs/BLAs
- ►Direct leadership in approvals for first-in-class therapies
- ►Veteran FDA & EMA experts and reviewers providing mock audit insights
- ►Oncology (Solid Tumors, Hematology, Immuno-Oncology)
- ►Complex toxicity management (renal, cardiac, hepatic)
- ►Advanced therapies (CAR-T, ADCs, oncolytic viruses, RNAi, gene therapy)
We match you with experts who possess the specific combination of MD (clinical execution), PhD (scientific rigor), and MBA (commercial strategy) relevant to your program's stage.
- ►Board positions at cutting-edge biotech companies
- ►Relationships with FDA, EMA, PMDA regulators
- ►Principal Investigators from top academic medical centers
- ►Chairs of Data Safety Monitoring Boards (DSMBs)
- ►Authors of pivotal guidelines (NCCN, ASCO, ESMO)
- ►Recognized "America's Top Oncologists"
Need Technology and AI Strategy Support?
Technology and AI advisory is now delivered through our dedicated Fractional CTO offering to ensure clear scope, pricing transparency, and direct founder involvement.
Explore Fractional CTO AdvisoryThree Engagement Models
Rapid Risk Assessment
When to use: You need a quick sanity check before a major decision or milestone.
What you get:
- ►Initial protocol complexity and feasibility scan
- ►Identification of red flags in inclusion/exclusion criteria
- ►High-level technology stack assessment
- ►Go/no-go recommendation with supporting rationale
Targeted Expert Consultation
When to use: You have a specific challenge that requires deep domain expertise.
Clinical & Regulatory:
- ►IND/BLA/NDA "Red Team" Review
- ►Phase 1/2 Protocol Design & Optimization
- ►Global Health Authority (GHA) Strategy
- ►Safety Review & Pharmacovigilance Audit
Technology & AI:
- ►AI Strategy & Governance Audit
- ►Clinical SaaS Platform Vendor Selection
- ►M&A Technology Integration Planning
- ►GenAI/RAG Proof-of-Concept Development
What you get:
- ►Direct engagement with domain expert (guaranteed founder involvement)
- ►Detailed written analysis with actionable recommendations
- ►Implementation roadmap with success metrics
- ►30-day post-engagement support
Program Readiness Board (PRB)
When to use: You're approaching a critical inflection point (IND filing, Phase 1b data readout, Series B fundraise) and need comprehensive de-risking.
What you get:
Week 1–2: Dual-Track Assessment
- ►Clinical Track: Complete protocol review, regulatory strategy, feasibility analysis
- ►Technology Track: Data architecture evaluation, AI opportunity identification, vendor stack audit
Week 3: Integration & Synthesis
- ►Joint findings session between clinical and technology experts
- ►Identification of critical disconnects between strategy and execution
- ►Risk prioritization matrix
Week 4: Deliverables
- ►Unified "Board-Ready" report with executive summary
- ►12-month implementation roadmap
- ►Specific protocol modifications and technology recommendations
- ►Investor-facing risk mitigation summary
Why Clients Choose Our Network
"Insider" Advantage
Our clinical experts work with major CROs and bring operational insights to your side of the table. You get the insider knowledge of how CROs think, price, and operate—without the vendor conflicts.
Owner's Representative Model
We don't replace your CRO or technology vendors. We act as your expert agent to:
- ►Validate vendor recommendations
- ►Hold them accountable for deliverables
- ►Identify gaps or inefficiencies early
- ►Provide objective "buy vs. build" guidance
Current, Relevant Expertise
Our experts maintain active C-level roles, giving you access to:
- ►Real-time market intelligence
- ►Current regulatory thinking
- ►Latest technology capabilities
- ►Emerging best practices
Guaranteed Founder Involvement
Unlike large consulting firms that staff projects with junior associates, our SOWs explicitly name the expert who will perform the work—and guarantee their direct participation.
Need dedicated executive leadership instead of network access? Explore Fractional CMO and Fractional CTO options.
Case Study: Protocol Rescue in Asia-Pacific
Late-stage oncology asset facing 40% patient dropout due to restrictive eligibility criteria. Trial timeline at risk of 12+ month delay.
Program Readiness Board assembled within 7 days. Restructured inclusion parameters, recommended hybrid site enrollment model, optimized monitoring burden.
- ►Patient retention improved by 28%
- ►Trial timeline reduced by 4.5 months
- ►>$22M in cost savings
- ►Asset successfully de-risked for next funding milestone
Integration with AyurDatta Services
Our KOL network seamlessly integrates with our full suite of services:
KOLs inform protocol design, endpoint selection, and site strategy
Technology experts ensure your data infrastructure supports advanced analytics and AI
Clinical and regulatory KOLs prepare submissions and anticipate health authority questions
PRB model provides program-level governance across clinical, regulatory, safety, and technology readiness
Quality Assurance & Compliance
- ►Minimum 15 years of relevant experience
- ►Verified track record of regulatory approvals or platform deployments
- ►Active conflict-of-interest screening
- ►Confidentiality and IP protection agreements
- ►All work performed under ICH-GCP, ISO 14155, and GDPR compliance
- ►AI recommendations include auditability and explainability
- ►Documentation suitable for regulatory inspection
- ►Quality review by AyurDatta leadership before delivery
Three Steps to Expert Access
Initial Consultation
30-minute confidential discussion of your challenge, timeline, and objectives.
Expert Matching & Proposal
We identify the right KOL(s) and provide a detailed SOW with guaranteed expert names, deliverables, and timeline.
Rapid Deployment
Engagement begins within 7 business days of SOW signature.
Frequently Asked Questions
Q: How do you select which experts to engage for my project?
We match based on three criteria: (1) specific therapeutic area and modality experience, (2) regulatory pathway familiarity, and (3) technology stack relevance. You'll receive expert bios before engagement begins.
Q: What if I need expertise outside your current network?
We maintain relationships with 200+ vetted specialists across oncology, rare diseases, and advanced therapies. If we don't have the right expert in-network, we'll identify and vet someone within 10 business days at no additional cost.
Q: Can I engage the same expert for multiple projects?
Yes. Many clients establish ongoing relationships with specific KOLs for continuity across their development program.
Q: How do you handle conflicts of interest?
All experts complete conflict disclosure before engagement. We screen for direct competitive conflicts and financial relationships that could compromise objectivity.
Q: What makes this different from traditional expert networks?
Traditional networks provide one-hour phone consultations with experts you'll never speak to again. We provide multi-week engagements with documented deliverables, implementation support, and guaranteed expert involvement—positioning them as strategic advisors to your program.
Ready to de-risk your program with world-class expertise?
Book a Strategy Call or explore our engagement models.